Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0985420090310020239
Laboratory Medicine and Quality Assurance
2009 Volume.31 No. 2 p.239 ~ p.246
Evaluation of Hemoglobin A1c on the Cobas Integra 800 Immunoassay and Tosoh HLC-723 G8 HPLC Analyzer
Park Hyung-Doo

Kim Hee-Jung
Kim Myong-Soo
Lee Soo-Youn
Kim Jong-Won
Abstract
Background: Hemoglobin A1c (HbA1c) is a good marker for the monitoring of glycemic control in patients with diabetes mellitus and various methods are used for determination of HbA1c. We evaluated the analytical performance of ion-exchange high-performance liquid chromatography system, standard mode (G8 SM) and variant mode (G8 VM) of Tosoh HLC-723 G8 (Tosoh Corporation, Japan) and Cobas Integra 800 (Roche Diagnostics, Germany) using new reagent (Tina-quant Hemoglobin A1c Gen.2, Roche Diagnostics) for immunoassay.

Methods: G8 SM, G8 VM, and Cobas Integra 800 were evaluated for linearity, precision, comparison of method, and speed. Variant II Turbo (Bio-Rad Laboratories, USA) was used for comparison test for above three analyzers.

Results: Three instruments showed within-run precision (CVs) of 0.52-1.12% in low level and 0.39-0.90% in high level control material. Total run precision (CVs) were in 0.95-1.26% in low level and 0.60-0.94% in high level control material. The linearity was good for the range of 4-15% and comparison with Variant II turbo was excellent with 0.9878-0.9977 of correlation coefficient. Analytical speed was 2 min/1 min in G8 SM, 3.5 min/1.5 min in G8 VM, and 14.7 min/18 sec in Cobas Integra 800, respectively.

Conclusions: HLC-723 G8 SM and VM, and Cobas Integra 800 were showed excellent linearity, precision, and comparison with other instrument. We should consider the characteristics including analytical method and speed in each instrument when clinical laboratory is planning to introduce different equipment for HbA1c determination.
KEYWORD
Hemoglobin A1c (HbA1c), Tosoh HLC-723 G8, Cobas Integra 800
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø